Therapeutic Antibodies Methods and Protocols /
| Autor Corporativo: | |
|---|---|
| Outros Autores: | |
| Resumo: | XVIII, 585 p. text |
| Idioma: | inglês |
| Publicado em: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2009.
|
| Edição: | 1st ed. 2009. |
| coleção: | Methods in Molecular Biology,
525 |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/978-1-59745-554-1 |
| Formato: | Recurso Eletrônico Livro |
Sumário:
- Recombinant Antigens
- Therapeutic Antibodies: Current State and Future Trends – Is a Paradigm Change Coming Soon?
- Preparation of Recombinant Viral Glycoproteins for Novel and Therapeutic Antibody Discovery
- Antibody Libraries
- Design of a Human Synthetic Combinatorial Library of Single-Chain Antibodies
- Construction of a Human Antibody Domain (VH) Library
- Generation and Selection of Rabbit Antibody Libraries by Phage Display
- Construction of a Large Naïve Human Phage-Displayed Fab Library Through One-Step Cloning
- Antibody Discovery
- Identification of Target and Function Specific Antibodies for Effective Drug Delivery
- Screening of Specific Internalization Fab Fragment from Human Naive Phage Library by Combinational Bio-Panning
- Competitive Antigen Panning for Selection of HIV-1 Neutralizing Human Monoclonal Antibodies Specific for gp41
- Selection of Non-aggregating VH Binders from Synthetic VH Phage-Display Libraries
- Isolation of Full-Length IgG Antibodies from Combinatorial Libraries Expressed in Escherichia coli
- Multiplexed Flow Cytometry: High-Throughput Screening of Single-Chain Antibodies
- Human Antibody Repertoires
- Rapid Screening Platform for Stabilization of scFvs in Escherichia coli
- Antibody Engineering
- In Vitro Antibody Affinity Maturation Targeting Germline Hotspots
- Affinity Maturation by Phage Display
- Production of Chimeric Heavy-Chain Antibodies
- Mammalian Cell Display for Antibody Engineering
- Improving Antibody Binding Affinity and Specificity for Therapeutic Development
- Construction and Production of an IgG-Like Tetravalent Bispecific Antibody for Enhanced Therapeutic Efficacy
- Deimmunization of Monoclonal Antibodies
- Anti-CD22 Onconase: Preparation and Characterization
- Antibody–Cytotoxic Agent Conjugates:Preparation and Characterization
- Antibody Preclinical Development
- High-Level Production of a Humanized ImmunoRNase Fusion Protein from Stably Transfected Myeloma Cells
- Antibody Fragment Expression and Purification
- Scaling-Up and Production of Therapeutic Antibodies for Preclinical Studies
- Antibody Production by the Gram-Positive Bacterium Bacillus megaterium
- Neutralization of HIV by Antibodies
- Dynamics of Antibody Domains Studied by Solution NMR
- In Vivo Method for Establishing Synergy Between Antibodies to Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor-2
- Passive Immunization with Human Neutralizing Monoclonal Antibodies Against HIV-1 in Macaque Models: Experimental Approaches
- Antibody Sequence Analysis
- Organizing, Exploring, and Analyzing Antibody Sequence Data: The Case for Relational-Database Managers.